Details for 2014800179
Up to date per 04.04.2026
Actions
Details for 2014800179
Granted/Registered
European Patent
10.08.2016 A
26.02.2020 B1
04.10.2013
US
201361887288 P
24.04.2014
US
201461983720 P
C12N 15/113 20100101AFI20150417BHEP
Owner
Alnylam Pharmaceuticals, Inc.300 Third Street Cambridge, MA 02142US
Icahn School of Medicine at Mount SinaiOne Gustave L. Levy Place New York, NY 10029US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
BETTENCOURT, Brian300 Third Street Cambridge, MA 02142US
FITZGERALD, Kevin300 Third Street Cambridge, MA 02142US
QUERBES, William300 Third Street Cambridge, MA 02142US
DESNICK, Robert, J.170 East 93rd Street New York, NY 10128US
YASUDA, Makiko100 Overlook Terrace Apartment 612 New York, NY 10040US
Information about Fees